Dialogues on Diversifying Clinical Trials
Successful Strategies for Engaging Women and Minorities
L’Enfant Plaza Hotel, Washington, DC
September 22-23, 2011
The FDA Office of Women’s Health in collaboration with the Society for Women’s Health Research held a two-day conference to share a best practices approach to successful and innovative recruitment, retention, and analysis of women and minorities in clinical research. Over 200 representatives from government, industry, patient advocates, and the scientific community came together to discuss strategies for increasing the participation of women and minorities in clinical trials.
The conference included roundtable discussions and presentations on research design, cultural and linguistic competency, federal policies and regulations, and community collaborations. The meeting also featured welcoming remarks by FDA Commissioner Margaret Hamburg and DHHS Deputy Assistant Secretary Garth Graham.
- Commissioner’s remarks
- Webcast and Speaker Presentations
- Journal Article: Dialogues on Diversifying Clinical Trials: Successful Strategies for Engaging Women and Minorities in Clinical Trials. Journal of Women’s Health. Volume 21: Issue 7
A special thank you to the FDA Office of Minority Health for their support and assistance with this conference.